Torsades de Pointe Associated with Trazodone Consumption.


Journal

Case reports in critical care
ISSN: 2090-6420
Titre abrégé: Case Rep Crit Care
Pays: United States
ID NLM: 101598416

Informations de publication

Date de publication:
2024
Historique:
received: 17 01 2024
revised: 16 03 2024
accepted: 12 04 2024
medline: 29 4 2024
pubmed: 29 4 2024
entrez: 29 4 2024
Statut: epublish

Résumé

Trazodone is a serotonin receptor antagonist and reuptake inhibitor commonly used to treat major depression disorder (MDD), anxiety, and sleep disorders. It is considered safe for the heart due to minimal anticholinergic effects. Prolonged QT intervals can cause polymorphic ventricular tachycardia, known as torsades de pointe (TdP). We present a case of a 67-year-old female with a history of MDD who developed trazodone-induced TdP. Trazodone may lead to QTc prolongation and TdP, potentially fatal even without risk factors for QTc prolongation. Close monitoring is essential to prevent adverse complications in trazodone users.

Identifiants

pubmed: 38680420
doi: 10.1155/2024/5759229
pmc: PMC11055644
doi:

Types de publication

Case Reports

Langues

eng

Pagination

5759229

Informations de copyright

Copyright © 2024 Hamid Khederlou and Vanoushe Azimi Pirsaraei.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest regarding the publication of this article.

Auteurs

Hamid Khederlou (H)

Department of Cardiology, Zanjan University of Medical Sciences, Zanjan, Iran.

Vanoushe Azimi Pirsaraei (V)

Student Research Committee, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.

Classifications MeSH